Scotts Miracle Gro (SMG) Could Be 56% Overvalued After Its Recent Rebound
Scotts Miracle-Gro Company Class A SMG | 0.00 |
Scotts Miracle-Gro (SMG) stock has attracted fresh attention after recent share price moves, with investors weighing its current valuation against fundamentals such as revenue of $3,470.8m and net income of $206.1m.
At a latest share price of $67.99, Scotts Miracle-Gro has seen short term momentum pick up, with a 7.63% 1 month share price return and a 14.40% year to date share price return. The 5 year total shareholder return is down 55.04%, which signals that recent optimism is emerging after a weaker long term experience for shareholders.
If you are looking beyond Scotts Miracle-Gro and want ideas with a different growth profile, now could be a useful time to scan 18 top founder-led companies
After the latest rebound in Scotts Miracle-Gro, the key question is whether the recent gains already reflect most of the opportunity or if the current valuation still leaves meaningful upside ahead as the next leg of the story plays out.
Most Popular Narrative: 56.3% Overvalued
According to the most followed narrative on Scotts Miracle-Gro, the fair value estimate of $43.49 sits well below the latest $67.99 close. This frames the current rebound as relatively full when compared with that narrative view.
SMG’s current valuation reflects lingering skepticism: concerns over cannabis demand, consumer spending softness, and execution risk. But it may also underappreciate the company’s positioning within professional cultivation.
Want to see what is driving that valuation gap for Scotts Miracle-Gro? The narrative leans heavily on projected earnings, margins and a future profit multiple that look very different from the recent share price action.
Result: Fair Value of $43.49 (OVERVALUED)
However, the Scotts Miracle-Gro narrative could be knocked off course if cannabis cultivation demand weakens further or if margin recovery efforts fail to gain traction.
Another View: SWS DCF Points to Undervaluation
While the most followed Scotts Miracle-Gro narrative tags the stock as 56.3% overvalued at a fair value of $43.49, the SWS DCF model points the other way, with a future cash flow value of $80.12 versus the current $67.99 price, suggesting the market may be pricing in a lot of caution.
If one model flags overvaluation and another sees value on offer, the real question is which set of assumptions you think better reflects how Scotts Miracle-Gro’s cash flows could evolve from here, and what margin of safety you are comfortable with as an investor.
Next Steps
Given the mixed signals around Scotts Miracle-Gro, this is a moment to move quickly. Review the data for yourself and form a clear view based on the 4 key rewards and 1 important warning sign.
Looking for more investment ideas beyond Scotts Miracle-Gro?
Do not stop with Scotts Miracle-Gro alone. Broaden your watchlist with fresh stock ideas so you are not relying on a single opportunity.
- Spot potential high return outliers early by scanning 20 elite penny stocks with strong financials that pair smaller market caps with stronger financial profiles.
- Zero in on quality at a reasonable price by reviewing the 47 high quality undervalued stocks that combine solid fundamentals with compressed valuations.
- Strengthen the defensive side of your portfolio by checking the 10 dividend fortresses that focus on higher yields backed by more robust balance sheets.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
